The claim
Scientific and medical claims about treatment required evidence review before reliance.
Independent public-source case study · APERTURE-CASE-2026-006
A Claims & Evidence Audit testing how far a high-impact medical treatment proposition can responsibly be supported by independent evidence.
Full public PDF available
This case has a directly accessible public PDF. The website page is an orientation layer; the linked document provides the full published research record or principal dossier.
Decision structure
Scientific and medical claims about treatment required evidence review before reliance.
Technical language and published sources could be interpreted more strongly than the evidence supported.
Study quality, source provenance, chronology, limitations, competing evidence and specialist dependency.
What the public evidence could support and where qualified medical judgment remained necessary.
PUBLIC PORTFOLIO CASE STUDY · COMPLETE PUBLIC DOCUMENT ACCESS
Start with the Principal Dossier for the long-form case record. The supporting documents below expose the published evidence products individually so a prospective client can inspect exactly what an Aperture case output contains.
PRIMARY LONG-FORM DOCUMENT
Full published long-form dossier for this case. This is the first document to inspect when evaluating the depth, structure and evidentiary treatment of Aperture's work.
No separate supporting PDF is required for this public case. The full case is contained in the Principal Dossier above.
One convenience ZIP containing every PDF displayed in this public library. Individual PDFs remain directly inspectable above.
Public proof, protected process. These are the published case documents intended for client inspection. Proprietary internal control logic, prompts, thresholds, internal QA architecture and other protected operating materials are not part of the public case library.
Central question
The case tests claims that appropriately selected men with localised prostate cancer can receive a short outpatient permanent-seed brachytherapy procedure with a greater-than-98% cure rate, together with related claims about duration, sexual function, urinary complications and alternatives.
Evidence cut-off: 14 August 2026. Status: Final public dossier v1.0, subject to right of reply.
Claims & Evidence Audit
Operating mode: Independent Public-Source Case Study. Not a client engagement. No medical advice is provided.
Overall determination
The investigation found that low-dose-rate permanent-seed brachytherapy is a real, established treatment capable of excellent outcomes in appropriately selected patients. The principal reliability problem was not fabricated science. It was the loss of material qualification when risk groups, denominators, endpoint definitions, follow-up periods, baseline function and modern alternatives were compressed into short public claims.
A proposition can be assembled from individually credible facts and still create an unreliable overall impression when the conditions attached to those facts disappear. The case demonstrates the difference between finding supporting evidence and determining what that evidence actually permits someone to claim.
This case is an independent public-source evidence review. It is not medical consultation, diagnosis or treatment advice. Individual treatment decisions require assessment by appropriately qualified clinicians.